{"id":"W2794768733","doi":"10.1093/schbul/sby015.234","title":"O7.5. LONG-TERM SAFETY AND TOLERABILITY OF BREXPIPRAZOLE IN PATIENTS WITH SCHIZOPHRENIA","year":2018,"lang":"en","type":"article","venue":"Schizophrenia Bulletin","topic":"Treatment of Major Depression","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Tolerability; Positive and Negative Syndrome Scale; Partial agonist; Adjunctive treatment; Clinical endpoint; Placebo; Psychology; Medicine; Schizophrenia (object-oriented programming); Adverse effect; Relapse prevention; Clinical Global Impression; Internal medicine; Randomized controlled trial; Psychiatry; Pharmacology; Agonist; Psychosis; Receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002484899,0.0003158988,0.0006327954,0.0001953135,0.00009054677,0.00001802977,0.0001372915,0.0001586041,0.00090846],"category_scores_gemma":[0.0001174915,0.0002372313,0.00006500893,0.0002488016,0.0004256968,0.00007289716,0.0001466835,0.0002763736,0.0001107105],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008651784,"about_ca_system_score_gemma":0.00009216384,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006562419,"about_ca_topic_score_gemma":0.0001055301,"domain_scores_codex":[0.9978951,0.00009742498,0.0005608809,0.0005959126,0.0004886205,0.0003620173],"domain_scores_gemma":[0.9986087,0.00008259189,0.000210122,0.0006794568,0.0002062054,0.0002129293],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03673895,0.0008693002,0.9401385,0.0001213195,0.00005909833,0.00002016517,0.0001091308,7.978368e-7,0.0003376973,0.00005476564,0.0002798054,0.02127042],"study_design_scores_gemma":[0.02316845,0.001634273,0.9714523,0.0005408264,0.00008359861,0.00001415367,0.000008563877,0.000005618121,0.00223273,0.00003462333,0.000604786,0.0002200579],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996857,0.000209019,0.00003041635,0.0009268409,0.0001021455,0.0008599808,0.00003208335,0.00007231164,0.0009102346],"genre_scores_gemma":[0.9948962,0.0000217847,0.004537807,0.00009433847,0.0001161647,0.00001738381,0.00006474277,0.00004312438,0.0002084804],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03131378,"threshold_uncertainty_score":0.9947,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005770614132853032,"score_gpt":0.2278070177356498,"score_spread":0.2220364036027968,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}